drugset / Trial / NCT02986607

Corticosteroid Rhythms in Hypoparathyroid Patients

NCT02986607 ↗

NaSingle-groupOpen-labelBasic science

Summary

The investigators hypothesise that parathyroid hormon (PTH) depletion interferes with normal activity of the hypothalamus-pituitary-adrenal (HPA)-axis and the renin-angiotensin-aldosterone-system (RAAS), which in turn may impact morbidity and quality of life. The main objective of the current study is to test if PTH deficiency influences the secretion of corticosteroids and whether any abnormalities in the HPA-axis and the RAAS-system can be reversed by PTH infusion.

Timeline

Start
2016-03
Primary completion
2018-01
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject parathyroid hormone 1-84 Unknown 0.5 ug/kg Subcutaneous
Subject parathyroid hormone 1-84 Unknown 50 ug Subcutaneous